Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

---

Goy A., Sinha R., Williams M. E., Besisik S., Drach J., Ramchandren R., ...Daha Fazla

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, cilt.31, sa.29, ss.3688-95, 2013 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 31 Sayı: 29
• Basım Tarihi: 2013
• Doi Numarası: 10.1200/jco.2013.49.2835
• Dergi Adı: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.3688-95
• İstanbul Üniversitesi Adresli: Evet

Özet

Purpose